ProPharma Group and The Planet Group announce unified brand and expanded capabilities. Learn more >

NDA Partners has joined ProPharma Group Regulatory Sciences

For more than a decade, NDA Partners’ Expert Consultants have worked side-by-side with our clients to achieve their drug and medical device development goals. NDA Partners’ Expert Consultants have now joined ProPharma Group; together forming the world’s leading provider of product development and regulatory services for clients seeking marketing authorizations with the FDA, EMA, and national competent authorities (NCAs) throughout Europe.

Our experienced team is comprised of former senior-level regulatory agency and industry executives, and we can work with you to develop product development and regulatory strategies, interact with the agencies, prepare submissions, and remediate, maintain, and improve regulatory compliance.

See Our Expanded Services

Supporting successful outcomes

We develop product development and regulatory strategies based on a solid scientific foundation, helping to ensure regulatory and market success from pre-approval of your product or medical device through post-approval launch, line extensions, and maintaining optimal regulatory status for both the FDA and EMA.

View Our Full Suite of Regulatory Sciences Services

Your single-source service provider

ProPharma Group is the global, independent provider of regulatory sciences, clinical research solutions, life science consulting, pharmacovigilance, and medical information services serving pharmaceutical, biotechnology, and medical device companies.

See How We Help At Every Step

ProPharma Group Overview



Need Help Navigating the Dynamic Regulatory Market to Bring Your Product Concept to Market?

Complete the form or call us at 540-738-2550 to discover how 30+ years of regulatory experience using a strategic and scientific approach can deliver successful and expeditious outcomes.

Interested in gaining an industry edge? Let us help you stay current.

 


All fields are required.
There was a problem with your submission. Errors have been highlighted below.